Literature DB >> 31285093

Electrochemotherapy for the palliative management of cutaneous metastases: A systematic review and meta-analysis.

Josephine Morley1, Patricia Grocott2, Edward Purssell3, Trevor Murrells2.   

Abstract

BACKGROUND: Electrochemotherapy combines electroporation in conjunction with chemotherapeutic agents and is used to treat tumours in many localisations, including cutaneous metastases. The symptoms associated with cutaneous malignant wounds can be distressing for patients and their management is a challenge in healthcare. AIM: The purpose of this systematic review was to investigate the effectiveness of electrochemotherapy in the context of palliative care.
DESIGN: All aspects of the systematic review were followed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. DATA SOURCES: The following databases were searched for English-language reviews; Medline, Embase, CINAHL, British Nursing Index and the Cochrane Library. The search was conducted between the publication of Standard Operating Procedures in 2006 and the third week of October 2017. Studies involving oral cancers and studies with fewer than 10 patients were excluded. The selected studies were assessed for risk of bias and sub-group data were synthesised in a random-effects meta-analysis.
RESULTS: From 425 studies, 29 studies were included involving 1503 patients, the pooled results were 46.6% for complete response and 82.2% for objective response according to the Response Evaluation Criteria in Solid Tumours. The meta-analysis indicated that small tumours were over twice as likely (2.25) to have a complete response than large.
CONCLUSIONS: Electrochemotherapy is an effective, repeatable and minimally invasive intervention within the palliative population that can reduce symptom burden. This review is an update of previous systematic reviews by Mali et al. [1,2] and highlights the need for tailored treatment depending on each individual case. Crown
Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Electrochemotherapy; Meta-analysis; Palliative care; Skin neoplasms; Systematic review; Treatment outcome

Mesh:

Substances:

Year:  2019        PMID: 31285093     DOI: 10.1016/j.ejso.2019.07.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Palliative Electrochemotherapy Treatment of Cutaneous Metastases in a Patient with Advanced Thyroid Papillary Carcinoma.

Authors:  Daniela Cavaco; Sara Carvalhal; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2020-06-05

2.  Electrochemotherapy of skin metastases from breast cancer: a systematic review.

Authors:  Martina Ferioli; Anna Myriam Perrone; Milly Buwenge; Alessandra Arcelli; Alice Zamagni; Gabriella Macchia; Francesco Deodato; Savino Cilla; Luca Tagliaferri; Francesca De Terlizzi; Pierandrea De Iaco; Claudio Zamagni; Alessio Giuseppe Morganti
Journal:  Clin Exp Metastasis       Date:  2020-11-12       Impact factor: 5.150

3.  Successful electrochemotherapy treatment of a large bleeding lymph node melanoma metastasis.

Authors:  Fredrik J Landström; Frida E Jakobsson; Stefan J Kristiansson
Journal:  Melanoma Manag       Date:  2022-06-30

Review 4.  Electrochemotherapy of skin metastases from malignant melanoma: a PRISMA-compliant systematic review.

Authors:  Luca Tagliaferri; Alessio G Morganti; Martina Ferioli; Valentina Lancellotta; Anna Myriam Perrone; Alessandra Arcelli; Andrea Galuppi; Lidia Strigari; Milly Buwenge; Francesca De Terlizzi; Silvia Cammelli; Roberto Iezzi; Pierandrea De Iaco
Journal:  Clin Exp Metastasis       Date:  2022-07-22       Impact factor: 4.510

Review 5.  Cutaneous metastasectomy: Is there a role in breast cancer? A systematic review and overview of current treatment modalities.

Authors:  Samantha Huang; Vishwas Parekh; James Waisman; Veronica Jones; Yuan Yuan; Nayana Vora; Richard Li; Jae Jung; Laura Kruper; Farah Abdulla; Yuman Fong; Wai-Yee Li
Journal:  J Surg Oncol       Date:  2022-04-07       Impact factor: 2.885

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.